Comparative effects of arabinosyl nucleosides upon the postnatal growth and development of the rat.
D000225:Adenine / Q000494:pharmacology; D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D000998:Antiviral Agents / Q000494:pharmacology; D001089:Arabinose / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D002531:Cerebellum / Q000187:drug effects / Q000254:growth & development / Q000473:pathology; D003561:Cytarabine / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D005467:Floxuridine / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D006128:Growth / Q000187:drug effects*; D007042:Hypoxanthines / Q000494:pharmacology; D007274:Injections, Intraperitoneal; D008124:Locomotion / Q000187:drug effects; D009043:Motor Activity / Q000187:drug effects; D009705:Nucleosides / Q000494:pharmacology; D051381:Rats; D013997:Time Factors
D000963:Antimetabolites; D000998:Antiviral Agents; D007042:Hypoxanthines; D009705:Nucleosides; D005467:Floxuridine; D003561:Cytarabine; D001089:Arabinose; D000225:Adenine